On April 3, 2015, Samsung Pharmaceutical Co., Ltd. closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,237 KRW | +0.32% | -4.18% | -11.83% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
11,700 KRW | +5.12% | +5.60% | 320M | ||
4,435 KRW | -0.34% | +1.49% | 34.32M | ||
1,637 KRW | +0.24% | +0.06% | 112M | ||
1st Jan change | Capi. | |
---|---|---|
-11.83% | 36.67M | |
+18.06% | 3.17B | |
+12.82% | 1.77B | |
+12.54% | 1.59B | |
-11.54% | 1.21B | |
+22.30% | 814M | |
+6.98% | 655M | |
+35.03% | 570M | |
+35.87% | 510M | |
-4.17% | 508M |
- Stock Market
- Equities
- A246690 Stock
- News T.S. Investment Corporation
- Samsung Pharmaceutical Co., Ltd. announced that it has received KRW 15.1 billion in funding from GemVax & Kael Co., Ltd. and other investors.